BTSG vs. FMS: BrightSpring Health Services vs. Fresenius Medical Care Stock Comparison

Company Profile

BrightSpring Health Services (BTSG) and Fresenius Medical Care (FMS) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.

Fresenius Medical Care (FMS) carries decades of public-market history since September 17, 1996, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the FMS side.

BrightSpring Health Services (BTSG) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Fresenius Medical Care (FMS) at 7.84% is closer to the peer norm — stronger capital efficiency for BTSG.

Both BrightSpring Health Services (BTSG) at 2.69% and Fresenius Medical Care (FMS) at 4.22% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both BrightSpring Health Services (BTSG) at 3.81% and Fresenius Medical Care (FMS) at 9.63% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Fresenius Medical Care (FMS) at 1.51% is in the bottom quartile, showing a clear gap in revenue momentum.

Only one side can be read here: Fresenius Medical Care (FMS) reports EPS growth of 83.61%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

BrightSpring Health Services (BTSG) at 1.62 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

Fresenius Medical Care (FMS) at 0.79 carries an industry-typical debt-to-equity mix, while BrightSpring Health Services (BTSG) at 1.09 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

BrightSpring Health Services (BTSG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a yield of 6.30%, ranking against industry peers normally.

BrightSpring Health Services (BTSG) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a payout of 50.14%, ranking against industry peers normally.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while BrightSpring Health Services (BTSG) at 47.62 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

Both BrightSpring Health Services (BTSG) at 0.88 and Fresenius Medical Care (FMS) at 0.62 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

Fresenius Medical Care (FMS) at 0.85 looks cheap against book in the lower P/B ratio quartile, while BrightSpring Health Services (BTSG) at 6.39 carries a premium in the upper quartile — a clear price-to-book gap.

Valuation Metrics